Stalmack Kathryn 4
4 · BioScrip, Inc. · Filed Apr 11, 2019
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
Stalmack Kathryn
General Counsel
Transactions
- Disposition to Issuer
Common Stock, $.0001 Par Value
2019-04-10$1.97/sh−22,235$43,803→ 71,510 total - Exercise/Conversion
Common Stock, $.0001 Par Value
2019-04-10+73,745→ 93,745 total - Exercise/Conversion
Restricted Stock Unit
2019-04-10−73,745→ 0 total→ Common Stock, $.0001 Par Value (73,745 underlying)
Footnotes (4)
- [F1]73,745 Restricted Stock Unites (RSUs) vested on the first anniversary of the original grant date (April 5, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 10, 2019.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
- [F3]This transaction represents shares withheld by the Company for tax withholding on Ms. Stalmack's settlement of the 73,745 RSUs that vested on April 5, 2019.
- [F4]The Restricted Stock Units vest in their entirety on the on the first anniversary of the date of grant.